Oncotarget

Corrections:

Correction: PreImplantation factor (PIF) protects cultured embryos against oxidative stress: relevance for recurrent pregnancy loss (RPL) therapy

PDF  |  How to cite

Oncotarget. 2018; 9:37344-37344. https://doi.org/10.18632/oncotarget.26505

Metrics: PDF 918 views  |   ?  

Lindsay F. Goodale1,6, Soren Hayrabedyan2, Krassimira Todorova2, Roumen Roussev3, Sivakumar Ramu3,8, Christopher Stamatkin3,9, Carolyn B. Coulam3, Eytan R. Barnea4,5,* and Robert O. Gilbert1,7,*

1 Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY, USA
2 Institute of Biology and Immunology of Reproduction, Bulgarian Academy of Sciences, Sofia, Bulgaria
3 CARI Reproductive Institute, Chicago, IL, USA
4 BioIncept, LLC, Cherry Hill, NJ, USA
5 Society for the Investigation of Early Pregnancy (SIEP), Cherry Hill, NJ, USA
6 Department of Population Health and Reproduction, School of Veterinary Medicine, University of California-Davis, Davis, CA, USA
7 Ross University School of Veterinary Medicine, Basseterre, St. Kitts, West Indies
8 Promigen Life Sciences, Downers Grove, IL, USA
9 Therapeutic Validation Core, Indiana University Simon Cancer Center, Indiana University School of Medicine, Indianapolis, IN, USA
* These authors have contributed equally to this work

Published: December 18, 2018

This article has been corrected: The correct Author name is given below:

Soren Hayrabedyan

Original article: Oncotarget. 2017; 8:32419-32432. DOI: https://doi.org/10.18632/oncotarget.16028.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 26505